Anti TNF- alpha Therapy in Rheumatoid Arthritis: A New Insight
Parsha Shanzana
, Tanjia Afrin Chowdhury , Marufatuzzahan
Tumor nacrosis factor alpha (TNF-α), anti TNF-α, rheumatoid arthritis (RA), disease modifying anti rheumatic antibody drugs (DMARDS), biologics
The development of anti Tumor nacrosis factor alpha (TNF-α) therapies is an alternative to the existing treatments of rheumatoid arthritis (RA). These anti TNF-α therapeutics aim to inhibit the inflammatory activities of TNF-α, which is the major cytokine causing the disease RA. Biologic agents are the newest forms of drugs to treat RA among the disease modifying anti rheumatic drugs (DMARDs). Though, these biologics do not cure the disease, but certainly slow down the progression of the disease with less risk. There are several monoclonal antibody based drugs and fusion proteins which are found to be remarkably successful in this regard. However, comparing the safety concern and immunogenic reactions of these therapeutics this review highlights on further improvements and efficacy of these drugs by subsiding the side effects.
"Anti TNF- alpha Therapy in Rheumatoid Arthritis: A New Insight", IJSDR - International Journal of Scientific Development and Research (www.IJSDR.org), ISSN:2455-2631, Vol.2, Issue 12, page no.110 - 115, December-2017, Available :https://ijsdr.org/papers/IJSDR1712016.pdf
Volume 2
Issue 12,
December-2017
Pages : 110 - 115
Paper Reg. ID: IJSDR_170881
Published Paper Id: IJSDR1712016
Downloads: 000347029
Research Area: Biological Science
Country: Sylhet, Sylhet, Bangladesh
ISSN: 2455-2631 | IMPACT FACTOR: 9.15 Calculated By Google Scholar | ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 9.15 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: IJSDR(IJ Publication) Janvi Wave
